Metabolic Reprogramming in Bladder Cancer: Molecular Drivers, Immune Regulation and Therapeutic Opportunities
Shaolin Li, Minghui Li, Yinglang Zhang, Jie Pu, Jiaao Sun, Chunsheng Li, Changgang Guo · 2026
Read Metabolic Reprogramming in Bladder Cancer: Molecular Drivers, Immune Regulation and Therapeutic Opportunities by Shaolin Li, Minghui Li, Yinglang Zhang, Jie Pu, Jiaao Sun, Chunsheng Li, Changgang Guo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13664454.txt.
Description
Shaolin Li and six colleagues review how bladder cancer rewires its metabolism, and how that shift steers immunity. Altered metabolism is now seen as a central driver of the cancer's variety and its response to treatment. The review pulls together genetic, epigenetic, and tumor-setting data. Tumors spread carbon and nitrogen across sugar burning, fat building, amino-acid use, and mitochondrial respiration. Certain mutations make tumors rely on certain fuels.
Waste products such as lactate and adenosine leak into the tissue around the tumor. There they blunt killer T cells and favor suppressive immune cells. That feeds resistance to chemotherapy and checkpoint drugs. The authors map treatment options: starving glycolysis, blocking fat and cholesterol synthesis, or using amino-acid needs. This twenty twenty-six synthesis links metabolism to immunotherapy success or failure.
Catalog record
| CREATOR | Shaolin Li, Minghui Li, Yinglang Zhang, Jie Pu, Jiaao Sun, Chunsheng Li, Changgang Guo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 105 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |